Interventional gastroenterologist Dr. Ivo Boskoski and interventional cardiologist Dr. Jacob Mishell bring important expertise around current and future Myka Labs pipeline products
Myka Labs announced today the addition of two key figures to its Clinical Advisory Board.
Dr. Ivo Boskoski is Assistant Professor of Gastroenterology at the Università Cattolica & Fondazione Policlinico Universitario Agostino Gemelli IRCCS Catholic University in Rome, Italy. Dr. Boskoski is a global leader in advanced endoscopic procedures and has authored over 150 papers including holding senior authorship on a number of important recent papers in the fields of gastroenterology and cancer, spanning topics from pancreatic insulinoma to malignant biliary obstruction to pancreatitis to metabolism. He is a key contributor in the European Society of Gastrointestinal Endoscopy’s assessment of opportunities and risks around artificial intelligence. Dr. Boskoski is a member of the American College of Gastroenterology, the European Society of Gastrointestinal Endoscopy and the American Society of Gastrointestinal Endoscopy, and is a member of the Advisory Board of the Italian Society of Young Gastroenterologists. He received his medical degree from the University of Perugia and holds a Ph.D. in experimental surgery from the Università Cattolica. At Myka Labs, he will play a key role in the development of Conflux for endoscopic bypass of malignancy-associated obstruction as well as broader corporate priorities around precision surgery.
Dr. Jacob Mishell is Director of the Structure Heart Program for Kaiser Permanente Northern California, a practicing interventional cardiologist with the Permanente Medical Group, and Assistant Clinical Professor of Medicine in the Division of Cardiology at the University of California, San Francisco. He is a member of the Society for Cardiovascular Angiography and Interventions; a Fellow of the American College of Cardiology; and a member of the American College of Physicians. He is heavily involved in clinical research, with leadership roles on major clinical studies in areas including transcatheter tricuspid valve replacement, transcatheter mitral valve repair and patent foramen ovale closure for stroke. He received his MD from the University of Rochster and completed his internship and residency at Johns Hopkins. At Myka Labs, Dr. Mishell is central to new initiatives inside the company to apply its industry-leading navigation systems technology in new areas, including structural heart.